SCHEMBL4763285

SCHEMBL4763285

C1COC2(CCC(SCC3CC3)CC2)O1.O=C1CCC(SCC2CC2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3541573 0.87
SCHEMBL3543591 0.82
SCHEMBL742157 0.74 GPR119 (0.33)
SCHEMBL8517346 0.74 GPR119 (0.38)
SCHEMBL14129084 0.71 GPR119 (0.41)
SCHEMBL422994 0.71 ALDH1A1 (0.33)
SCHEMBL46361 0.70 KMT2A (0.34)
SCHEMBL19339358 0.70 ALDH1A1 (0.33)
Water SCHEMBL31387323 0.68 ALDH1A1 (0.33)
SCHEMBL19884668 0.66 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893566-A1 CYCLOHEXANESULFONYL DERIVATIVES AS GLYT1 INHIBITORS TO TREAT SCHIZOPHRENIA MERCK SHARP &amp; DOHME LTD. (GB) 2008-03-05 EP disclosed
WO-2006131711-A1 CYCLOHEXANESULFONYL DERIVATIVES AS GLYT1 INHIBITORS TO TREAT SCHIZOPHRENIA MERCK SHARP & DOHME LIMITED (GB) 2006-12-14 WO disclosed